We believe in Leveraging Innovative Technology to Provide Accessible Healthcare Enhancing Everyone’s Quality of Life

The importance
of early detection

Currently, in spite of the technological progress made in various fields, 50% of chronic diseases and cancers are diagnosed at a late stage, when treatment efficacy is low. Prevention or early diagnosis through innovative technologies can mitigate the suffering caused by late-stage disease diagnoses.

Early diagnosis is pivotal in effectively managing and treating diseases before they escalate into more severe conditions like cancer. Additionally, effective patient management and timely treatment can dramatically improve outcomes and save lives when illness is unavoidable.

The Dianose

This has led us to develop a different approach to sensing technology. We have developed a remote condition management device based on cutting-edge technology using Nano technology and machine learning to achieve this vision of a healthier future for all. With Dianose, we offer a vital, user-friendly tool so that patients and healthcare professionals alike can take early action and implement intensive monitoring and care. This will result in lives saved and reduced suffering.

We are committed to continuing to push the boundaries of technology to make healthcare more accessible and effective for everyone.

In 2024, NaNose Medical received a significant grant from the EU-EIC to support its ReLiV project.

Our Technology

Nanose Medical – Power of Nanotechnology & Artificial Intelligence –

As Easy As Breathing !

Noninvasive

Portable handheld device

Rapid results

Simple - reduces user skill dependency

Portable handheld device

Rapid results

Noninvasive

Simple - reduces user skill dependency

Affordable

High accuracy

Affordable

High accuracy

Nanose Medical - fighting lung cancer

Nanose Medical is taking part in LUCIA an international project and consortium supported by the Horizon Europe Program with the mission of improving early detection and management of lung cancer